Syneron Medical Ltd
ELOS
ELOS was delisted on the 14th of July, 2017.
4 hedge funds and large institutions have $34.6M invested in Syneron Medical Ltd in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 73 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
85% less capital invested
Capital invested by funds: $235M → $34.6M (-$200M)
95% less funds holding
Funds holding: 79 → 4 (-75)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 73
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$25.7M |
| 2 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
-$17.4M |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$16.2M |
| 4 |
KPF
K2 Principal Fund
Toronto,
Ontario, Canada
|
-$12.1M |
| 5 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
-$9.64M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
NFG
76
Next Financial Group
Houston,
Texas
| – | -$3K | -300 | Closed |
|
77
Bank of America
Charlotte,
North Carolina
| – | -$1K | -76 | Closed |
|
ELOS Hedge Fund Activity: Q3 2017 in Review
4 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q3 2017, worth a combined $34.6M — down 85% from $235M a quarter earlier.
Sellers outnumbered buyers: 73 funds closed out of ELOS and 0 opened new positions — a net loss of 73 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Camber Capital Management, exiting entirely with an estimated $25.7M sold.
- 4 institutional investors held Syneron Medical Ltd (ELOS) as of Q3 2017, down from 79 in Q2 2017.
- Funds reported $34.6M of Syneron Medical Ltd stock for Q3 2017, down 85% quarter-over-quarter.
- 0 funds opened new Syneron Medical Ltd positions in Q3 2017 and 73 closed out, a net change of -73 holders.
- The largest Syneron Medical Ltd seller in Q3 2017 was Camber Capital Management, an estimated $25.7M sold.
Based on aggregated 13F filings for Q3 2017.